Yikang Shi

4PUBLICATIONS
0CO-AUTHORS
GlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 23, 2023
Improved Antitumor Efficacy of a Dextran-based Docetaxel-coupled Conjugate against Triple-Negative Breast Cancer.

Hongshuai Lv, Weiping Jia, Peng Dong

|Oct 20, 2022
A Novel Dextran-Based Dual Drug Conjugate Targeted Tumors with High Biodistribution Ratio of Tumors to Normal Tissues.

Jiaojiao Liu, Naining Zhang, Jiaan Wu

|Jun 01, 2022
The enhanced antitumor activity of the polymeric conjugate covalently coupled with docetaxel and docosahexaenoic acid.

Peng Dong, Jiaojiao Liu, Hongshuai Lv

|Aug 06, 2017
Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.

Shengshi Huang, Di Wang, Shu Zhang

Pageof 1

Frequent Collaborators